EC expands indication for Gilead’s Veklury to treat Covid-19 patients
The EC’s decision is based on data from a randomised, placebo-controlled, double-blind Phase III trial...
News
Sanofi to acquire immuno-oncology firm Amunix for $1bn
With the takeover, Sanofi will gain access to TCEs, cytokine therapies as well as various...
Aridis’ antibody cocktail shows activity against Covid-19 variants
AR-701 combination is intended to provide ample drug levels for up to a year from...
Novartis signs deal with BeiGene to bolster immunotherapy pipeline
Under the deal, BeiGene will get an upfront payment of $300m from Novartis.
EU to procure over 200 million doses of Pfizer-BioNTech’s Comirnaty
The latest option exercise to buy additional doses is part of the agreement signed in...
Pharmaceutical Technology Excellence Awards 2021 – Winners Announced!
The results are in for the Pharmaceutical Technology Excellence Awards. Download our free report to find out who this year's winners are.
Bharat Biotech seeks approval for Phase III intranasal Covid-19 vaccine trial
India’s CDSCO approved expanding the shelf life of the company’s Covaxin by up to one year from the date of manufacture.
FDA approves AstraZeneca-Amgen’s Tezspire for severe asthma treatment
The approval is based on data from the PATHFINDER trial programme and Phase III NAVIGATOR trial of the antibody.
EC grants marketing authorisation to GSK-Vir’s Xevudy for Covid-19
In a Phase III trial, sotrovimab showed a 79% decline in all-cause hospitalisations for over 24 hours or mortality by day 29.
Novavax and SII obtain WHO Emergency Use Listing for Covid-19 vaccine
Under the latest EUL, SII-manufactured vaccines are authorised to be sold as COVOVAX in India as well as licenced regions.
Scottish Medicines Consortium approves three cancer drugs for NHS use
The three approved drugs are AstraZeneca’s olaparib, Bristol-Myers Squibb’s nivolumab and AbbVie’s ibrutinib.
